KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Non-Current Assets (2016 - 2026)

Teva Pharmaceutical Industries filings provide 18 years of Non-Current Assets readings, the most recent being $26.3 billion for Q1 2026.

  • On a quarterly basis, Non-Current Assets fell 2.07% to $26.3 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $107.8 billion, a 4.47% decrease, with the full-year FY2025 number at $26.8 billion, changed 0.1% from a year prior.
  • Non-Current Assets hit $26.3 billion in Q1 2026 for Teva Pharmaceutical Industries, down from $26.8 billion in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $34.6 billion in Q1 2022 to a low of $26.3 billion in Q1 2026.
  • Median Non-Current Assets over the past 5 years was $30.5 billion (2024), compared with a mean of $29.9 billion.
  • Biggest five-year swings in Non-Current Assets: decreased 13.62% in 2024 and later grew 0.1% in 2025.
  • Teva Pharmaceutical Industries' Non-Current Assets stood at $32.0 billion in 2022, then fell by 3.02% to $31.0 billion in 2023, then decreased by 13.62% to $26.8 billion in 2024, then grew by 0.1% to $26.8 billion in 2025, then decreased by 1.76% to $26.3 billion in 2026.
  • The last three reported values for Non-Current Assets were $26.3 billion (Q1 2026), $26.8 billion (Q4 2025), and $27.1 billion (Q3 2025) per Business Quant data.